CryoPort (NASDAQ:CYRX) Insider Sells 10,000 Shares of Stock

CryoPort, Inc. (NASDAQ:CYRX) insider Mark Sawicki sold 10,000 shares of the company’s stock in a transaction on Tuesday, November 10th. The shares were sold at an average price of $19.93, for a total value of $199,300.00. Following the completion of the transaction, the insider directly owned 92,356 shares in the company, valued at approximately $1,840,655.08. The trade was a 9.77% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

CryoPort Stock Performance

CYRX stock traded down $0.46 during midday trading on Thursday, reaching $20.10. The stock had a trading volume of 659,177 shares, compared to its average volume of 664,215. The stock has a market cap of $1.02 billion, a PE ratio of -20.72 and a beta of 1.89. The firm has a fifty day simple moving average of $17.26 and a two-hundred day simple moving average of $13.61. CryoPort, Inc. has a 52-week low of $7.61 and a 52-week high of $21.78.

CryoPort (NASDAQ:CYRX) last issued its quarterly earnings results on Thursday, November 5th. The company reported ($0.25) EPS for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.07). The firm had revenue of $50.22 million for the quarter, compared to analyst estimates of $48.66 million. CryoPort had a negative return on equity of 8.28% and a negative net margin of 21.46%. On average, sell-side analysts predict that CryoPort, Inc. will post -0.88 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the company. Needham & Company LLC raised their price objective on CryoPort from $19.00 to $28.00 and gave the stock a “buy” rating in a research note on Friday, November 6th. Robert W. Baird set a $26.00 target price on CryoPort in a research report on Tuesday, October 13th. BTIG Research upped their target price on CryoPort from $25.00 to $26.00 and gave the company a “buy” rating in a research report on Tuesday, October 13th. Roth Capital reiterated a “buy” rating and issued a $21.00 price target on shares of CryoPort in a report on Friday, August 7th. Finally, Piper Sandler raised shares of CryoPort to a “buy” rating in a research report on Tuesday, October 13th. Seven analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $21.69.

Institutional Trading of CryoPort

Several hedge funds and other institutional investors have recently bought and sold shares of CYRX. Wellington Management Group LLP purchased a new position in CryoPort during the second quarter valued at approximately $8,398,000. Roubaix Capital LLC lifted its holdings in CryoPort by 12.4% in the third quarter. Roubaix Capital LLC now owns 454,926 shares of the company’s stock valued at $7,916,000 after acquiring an additional 50,148 shares during the period. Royce & Associates LP purchased a new stake in CryoPort in the 3rd quarter worth approximately $7,073,000. Russell Investments Group Ltd. boosted its position in CryoPort by 376.7% in the 3rd quarter. Russell Investments Group Ltd. now owns 399,047 shares of the company’s stock worth $6,943,000 after purchasing an additional 315,343 shares in the last quarter. Finally, Squarepoint Ops LLC boosted its position in CryoPort by 685.1% in the 2nd quarter. Squarepoint Ops LLC now owns 368,424 shares of the company’s stock worth $5,784,000 after purchasing an additional 321,497 shares in the last quarter. 92.90% of the stock is owned by institutional investors and hedge funds.

About CryoPort

Cryoport, Inc. provides temperature-controlled supply chain services for the life sciences industry. Its offerings support the development and commercial distribution of cell and gene therapies, biologics, reproductive medicine products and other temperature-sensitive materials. The company’s services include specialized shipping systems and packaging, transportation management, cryogenic storage, shipment monitoring and logistics support. These solutions are designed to help customers maintain required conditions and manage the handling of sensitive materials across clinical and commercial supply chains.